Stock Market News & Analysis

stocks
Ask the analyst: Can ASX growth story turn a profit before it’s too late?
This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.
Ask the analyst: Can ASX growth story turn a profit before it’s too late?
Ask the analyst: Can ASX growth story turn a profit before it’s too late?
stocks
12 picks for an income portfolio - Q2 2025 update

12 picks for an income portfolio - Q2 2025 update

One year in and passive income growth has exceeded my target.
stocks
Stock showdown: Does Sigma Healthcare deserve a similar market value to Woolies?

Stock showdown: Does Sigma Healthcare deserve a similar market value to Woolies?

Sigma’s merger with Chemist Warehouse has brought one of Australia’s best retail businesses to the public.
stocks
Bolt-on acquisition adds capabilities for undervalued ASX share

Bolt-on acquisition adds capabilities for undervalued ASX share

Shares are trading at a 61% discount to our fair value.
stocks
How to understand potential investments at a deeper level

How to understand potential investments at a deeper level

Asking these simple questions can reveal valuable things about a company’s quality and economics.
stocks
ASX healthcare leader undervalued after share slump

ASX healthcare leader undervalued after share slump

The sell-off in this moated healthcare company ignores strong potential for revenue growth and margin improvement.
stocks
Our view on Xero’s big bet

Our view on Xero’s big bet

The shares sold off after the announcement of the Melio Payments acquisitions.
stocks
10 cheap wide-moat US stocks for 2025

10 cheap wide-moat US stocks for 2025

Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.
stocks
3 cheap fully franked stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.
stocks
Ask the analyst: Why does the Santos story need to end like this?

Ask the analyst: Why does the Santos story need to end like this?

Santos’ disappointing returns over the past twenty years are mostly a result of bad timing. The timing of its potential departure from the ASX could also be unfortunate.
stocks
Can a deep value approach work for individual investors?

Can a deep value approach work for individual investors?

Featuring what was probably the most interesting stock pitch at Morningstar’s recent conference for advisers.
stocks
A safer ASX insurance play

A safer ASX insurance play

Why earnings may be more resilient in this corner of the insurance industry.
stocks
Undervalued ASX share despite headwinds

Undervalued ASX share despite headwinds

These shares with a strong dividend yield look attractive.
stocks
Ask the analyst: Why does Telstra have a moat and TPG doesn’t?

Ask the analyst: Why does Telstra have a moat and TPG doesn’t?

Being part of an oligopoly isn’t always enough to be awarded a moat by our analysts.
stocks
Bull or bear? Here’s how the outlook for US stocks stacks up

Bull or bear? Here’s how the outlook for US stocks stacks up

Headwinds and tailwinds are roughly in balance, but the outlook could tilt either way.
stocks
Chart of the Week: Virgin pre-IPO analysis

Chart of the Week: Virgin pre-IPO analysis

Why is finding success as an airline so difficult?
of 237
Viewing 1 to 16 of 3778